Schedule an Appointment

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information

Simy Skin Inc.

Location: West Palm Beach, Florida

Sector: Retail

Add to Shortlist
Express Interest

SimySkin helps women naturally lessen the effects of time on their skin at each phase of their lives. We do this by developing, producing and selling targeted Vitamin B12 based products which prevent, maintain, and repair the integrity of the skin.

Business Documents

MG cp Summary
  • Oncology Approach – SimySkin™ is a pioneer, teaming up with a prominent oncologist to help determine the effect of each ingredient used in the formulation of the Company’s anti-aging products. The oncology approach is combined with the principles of systems biology to develop better formulations.
  • Signature Ingredient – The Vitamin B12 is our signature ingredient. We have an intimate knowledge of how it works best, which helps in the formulation and the delivery method of our products based on the principles of systems biology.
  • Intellectual Property – SimySkin™ has an agreement with Kyto IP to use its Vitamin B12 IP. Kyto has assembled a portfolio of 21 pending or granted patents, related to B12 targeting technology and filed for protection in USA, Canada, Japan and Europe.
  • Value for Money – We combine the best of French and American formulation and manufacturing, are more generous with active ingredients and offer great value per ml size for the sophisticated consumer.

 

 

SimySkin helps women naturally lessen the effects of time on their skin at each phase of their lives. We do this by developing, producing and selling targeted Vitamin B12 based products which prevent, maintain, and repair the integrity of the skin.

Georges Benarroch, CEO & Founder
Georges Benarroch has developed specialized expertise in corporate finance and investing as an investment banker for over 30 years. After obtaining multiple graduate and post-graduate degrees in law, political sciences and international relations from Universities in France and Canada, he began his banking career in Paris. He then established his own private investment banking firm in the USA and in Canada
For the past 3 decades, Georges Benarroch has been a successful financial intermediary and investor. He has created and managed institutional brokerage as well as wealth management firms. Today he operates through Comindus Finance.

Dr. Uri Sagman, M.D., FRCPC, Special Adviser and Scientific Research
Dr. Sagman is a well-respected researcher who has received numerous awards and citations including the Young Investigator awards of the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR).
Dr. Uri Sagman is a highly respected oncologist who has co-founded a nanomedicine company focused on the development of fullerene antioxidants for the treatment of Parkinson’s disease, Alzheimer’s disease and certain skin conditions related to aging and UV exposure.